Security Snapshot

CROSS COUNTRY HEALTHCARE INC - Common Stock (CCRN) Institutional Ownership

CUSIP: 227483104

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

147

Shares (Excl. Options)

26,064,361

Price

$8.10

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
CCRN on Nasdaq
Shares outstanding
32,198,500
Price per share
$9.40
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
26,064,361
Total reported value
$211,122,665
% of total 13F portfolios
0%
Share change
-5,786,968
Value change
-$85,887,203
Number of holders
147
Price from insider filings
$9.40
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • CCRN - CROSS COUNTRY HEALTHCARE INC - Common Stock is tracked under CUSIP 227483104.
  • 147 institutions reported positions in Q4 2025.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 147 to 15 between Q4 2025 and Q1 2026.
  • Reported value moved from $211,122,665 to $2,003,708.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 147 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 227483104?
CUSIP 227483104 identifies CCRN - CROSS COUNTRY HEALTHCARE INC - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of CROSS COUNTRY HEALTHCARE INC - Common Stock (CCRN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.5% -13% $32,212,933 -$5,237,017 2,468,424 -14% BlackRock, Inc. 30 Jun 2025
Magnetar Financial LLC 5% -9.3% $20,594,124 -$2,318,016 1,631,864 -10% Magnetar Financial LLC 08 Dec 2025
DIMENSIONAL FUND ADVISORS LP 5% $15,130,719 1,609,925 Dimensional Fund Advisors LP 31 Mar 2026
GOLDMAN SACHS GROUP INC 3.9% -32% $18,057,017 -$8,745,113 1,271,621 -33% THE GOLDMAN SACHS GROUP, INC. 30 Sep 2025
ALLIANCEBERNSTEIN L.P. 0.1% -97% $251,593 -$15,310,018 31,215 -98% AllianceBernstein L.P. 31 Dec 2025

As of 31 Dec 2025, 147 institutional investors reported holding 26,064,361 shares of CROSS COUNTRY HEALTHCARE INC - Common Stock (CCRN). This represents 81% of the company’s total 32,198,500 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CROSS COUNTRY HEALTHCARE INC - Common Stock (CCRN) together control 63% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.8% 2,522,204 -3.8% 0% $20,429,853
DIMENSIONAL FUND ADVISORS LP 5.9% 1,905,849 -0.11% 0% $15,437,779
VANGUARD GROUP INC 5.9% 1,904,150 +4.5% 0% $15,423,615
ODDO BHF ASSET MANAGEMENT SAS 4% 1,272,700 -19% 0.39% $10,308,870
Sio Capital Management, LLC 3.3% 1,068,821 1.4% $8,657,450
Quinn Opportunity Partners LLC 3.2% 1,045,620 0.37% $8,469,522
Dana Investment Advisors, Inc. 3.1% 1,008,525 +71% 0.24% $8,169,053
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 3% 969,458 +28% 0% $7,852,610
AMERICAN CENTURY COMPANIES INC 2.9% 949,267 -2.9% 0% $7,689,063
GEODE CAPITAL MANAGEMENT, LLC 2.8% 893,620 +1.7% 0% $7,239,921
Boston Partners 2.5% 791,794 0.01% $6,414,012
STATE STREET CORP 2.3% 732,455 +23% 0% $5,932,886
Aristotle Capital Boston, LLC 1.9% 626,107 -9.1% 0.28% $5,071,467
Qube Research & Technologies Ltd 1.8% 571,927 -20% 0.01% $4,632,609
SYSTEMATIC FINANCIAL MANAGEMENT LP 1.7% 547,768 -22% 0.1% $4,436,927
Magnetar Financial LLC 1.6% 507,787 -79% 0.04% $4,113,075
FMR LLC 1.4% 442,464 +1379% 0% $3,583,962
BARCLAYS PLC 1.2% 398,851 +805% 0% $3,230,693
ROYCE & ASSOCIATES LP 1.2% 395,995 0.03% $3,207,559
GABELLI FUNDS LLC 1.1% 368,632 +0.37% 0.02% $2,985,919
BANK OF AMERICA CORP /DE/ 1.1% 343,216 +430% 0% $2,780,050
CITADEL ADVISORS LLC 1% 328,162 0% $2,658,112
NORTHERN TRUST CORP 0.91% 294,194 -6.5% 0% $2,382,971
Prescott Group Capital Management, L.L.C. 0.88% 282,910 0.21% $2,291,571
MARSHALL WACE, LLP 0.84% 271,381 +1321% 0% $2,198,186

Institutional Holders of CROSS COUNTRY HEALTHCARE INC - Common Stock (CCRN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 213,227 $2,003,708 +$81,918 $9.40 15
2025 Q4 26,064,361 $211,122,665 -$85,887,203 $8.10 147
2025 Q3 31,687,312 $450,047,057 +$3,202,466 $14.20 166
2025 Q2 31,504,997 $411,222,338 -$9,167,194 $13.05 159
2025 Q1 31,987,957 $476,365,692 -$6,896,154 $14.89 158
2024 Q4 31,763,189 $576,807,920 -$26,576,295 $18.16 174
2024 Q3 34,428,222 $462,481,461 +$2,428,663 $13.44 178
2024 Q2 34,572,008 $478,509,490 -$18,081,269 $13.84 162
2024 Q1 35,555,762 $665,618,904 -$21,624,815 $18.72 173
2023 Q4 36,869,415 $834,711,162 -$8,741,395 $22.64 173
2023 Q3 37,136,979 $920,623,664 -$13,115,165 $24.79 187
2023 Q2 37,009,862 $1,039,233,444 -$3,624,973 $28.08 190
2023 Q1 37,743,386 $842,372,865 +$31,959,348 $22.32 198
2022 Q4 35,917,572 $954,498,475 -$17,467,658 $26.57 230
2022 Q3 36,487,662 $1,035,192,856 +$18,308,369 $28.37 190
2022 Q2 36,013,006 $750,085,709 +$20,609,097 $20.83 173
2022 Q1 35,413,942 $767,327,226 +$23,176,130 $21.67 189
2021 Q4 34,022,608 $943,371,976 -$13,994,614 $27.76 180
2021 Q3 34,261,975 $727,537,294 +$5,845,611 $21.24 155
2021 Q2 34,136,940 $563,692,367 +$2,732,323 $16.51 145
2021 Q1 34,056,118 $425,425,640 +$10,999,576 $12.49 127
2020 Q4 33,242,318 $294,881,895 -$5,246,529 $8.87 120
2020 Q3 34,028,181 $220,783,385 -$577,784 $6.49 115
2020 Q2 34,196,745 $210,673,003 -$9,160,509 $6.16 120
2020 Q1 35,442,444 $238,838,726 -$1,886,194 $6.74 135
2019 Q4 35,325,914 $410,361,986 +$5,763,378 $11.62 135
2019 Q3 35,026,559 $360,788,377 +$1,988,909 $10.30 129
2019 Q2 34,994,780 $327,317,018 +$3,643,704 $9.38 119
2019 Q1 35,104,033 $246,792,414 +$17,614,189 $7.03 128
2018 Q4 32,496,508 $238,641,926 -$9,096,085 $7.33 140
2018 Q3 33,650,995 $293,775,190 +$4,335,783 $8.73 131
2018 Q2 32,728,475 $368,232,924 -$24,130,956 $11.25 136
2018 Q1 34,910,888 $387,885,595 +$2,693,896 $11.11 132
2017 Q4 34,440,967 $439,780,690 +$9,358,242 $12.76 141
2017 Q3 33,590,105 $477,912,751 -$14,032,136 $14.23 148
2017 Q2 34,853,975 $449,926,590 +$11,753,704 $12.91 141
2017 Q1 33,956,039 $487,604,986 +$77,519,692 $14.36 151
2016 Q4 32,268,281 $503,526,845 +$4,065,021 $15.61 155
2016 Q3 32,442,238 $382,065,320 +$5,990,268 $11.78 143
2016 Q2 31,796,502 $442,560,356 -$643,481 $13.92 145
2016 Q1 32,194,247 $374,397,105 -$5,055,233 $11.63 150
2015 Q4 31,817,035 $521,421,497 +$38,611,882 $16.39 164
2015 Q3 30,527,265 $415,467,095 +$7,763,382 $13.61 140
2015 Q2 30,062,763 $381,184,751 -$6,457,970 $12.68 123
2015 Q1 30,623,486 $362,970,200 +$9,345,046 $11.86 118
2014 Q4 29,764,106 $371,193,521 -$276,957 $12.48 123
2014 Q3 30,012,485 $278,724,742 +$8,932,003 $9.29 122
2014 Q2 29,010,977 $189,219,994 -$9,304,466 $6.52 115
2014 Q1 29,954,010 $241,383,896 +$8,724,067 $8.07 119